Share this journal
ISSN print
ISSN online
2; 1 issues
Latest content online 21 December 2019
Next issue
Next content due in 2020
Back volumes
Biochemistry, Molecular, Cell, Biology, Stem Cell

COVID-19 Statement – The current COVID-19 crisis is affecting many lives, and also research initiatives. We appreciate the efforts of our editors, authors, and reviewers working on our journal at this difficult time. See the full StemJournal (STJ) COVID-19 statement here.

Search & Submit Preprints 
– Via our preprint portal StemRxiv, you can keep up-to-date on the latest research developments by searching stem cell preprints and also submit your preprint via (and transfer to) StemJournal. Find out more here

Submit Your Research
–STJ is welcoming submissions! Read our "Call for Papers" here & view the first published articles in the journal here.

Sign Ups & Social Media –Be sure to sign up for news and updates at: You can view our latest newsletter here. Why not also join in the discussion via social media? Find us at:

Open Access Fee Discount Notification – STJ is an open access journal and we are pleased to announce that the open access fees are discounted by 80% for papers submitted in 2020.

StemJournal is an international, multidisciplinary publication for communicating outstanding stem cell research, including basic biology, clinical applications, disease modeling, computational and systems biology, and data science. It promises to be open new scientific contributions from the many fields of research on stem cells. The journal publishes original, peer-reviewed content covering a wide range of topics related to stem cell research, including research reports,  review articles, protocols, and more. This is an online journal that follows an open access model – visit at View the full Aims & Scope on the journal website here.

StemJournal is a sister publication to the stem cell community portal StemBook – visit at stembook.orgStemJournal and StemBook are the first components in IOS Press' forthcoming StemHub (read our related press releases, herehere). New components include: StemMeets (meeting abstracts) and StemRxiv (preprints).



Chad A. Cowan, PhD

Harvard Stem Cell Institute, Division of Cardiovascular Medicine, Department of Medicine
Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, MA, USA

Niels Geijsen, PhD
Leiden University Medical Center 
Professor Developmental Biology and Regenerative Medicine
Leiden, the Netherlands


Senior Editors

Laurence Daheron, PhD
Harvard Department of Stem Cell and Regenerative Biology, Harvard University
Cambridge, MA, USA

Winston Hide, PhD
Beth Israel Deaconess Medical Centre, Harvard Medical School
Boston, MA, USA

Agnete Kirkeby, PhD
Novo Nordisk Foundation for Stem Cell Biology (DanStem), Faculty of Health and Medical Sciences
University of Copenhagen
Copenhagen, Denmark

Stephanie Willerth, PhD
Mechanical Engineering & Division of Medical Sciences
University of Victoria,
Victoria, Canada

Associate Editors

Kristen Brennand, PhD, Icahn School of Medicine, USA
Qiurong Ding, PhD, Shanghai Institutes for Biological Sciences, China
Jenna Galloway, PhD, Harvard Medical School, USA
Jacob Hanna, MD, PhD, Weizmann Institute of Science, Israel
Lyn Healy, PhD, The Francis Crick Institute, UK
Jonathan Hoggatt, PhD, Massachusetts General Hospital, Harvard Medical School (Cancer Center and Center for Transplantation Sciences), USA
Shannan Ho Sui, PhD, Harvard Chan School of Public Health, USA
Insoo Hyun, PhD, Case Western Reserve University,USA
Darrell N. Kotton, MD, Boston University's Center for Regenerative Medicine, USA
Kathy O. Lui, PhD, The Chinese University of Hong Kong, Hong Kong
Florian Merkle, PhD, Wellcome, MRC Cambridge Stem Cell Institute, UK
Louise E. Purton, PhD, St Vincent's Institute, Australia
Evan Y. Snyder, MD, PhD, FAAP, Sanford Burnham Prebys Medical Discovery Institute (Center for Stem Cells & Regenerative Medicine), USA
Takanori Takebe, MD, Tokyo Medical and Dental University (Institute of Research), Japan
Ludovic Vallier, PhD, Wellcome, MRC Cambridge Stem Cell Institute, UK
Joseph C. Wu, MD, PhD, Stanford School of Medicine, USA
Wenli Yang, PhD, Penn Institute for Regenerative Medicine, USA

Editorial Advisory Board

James A. Adjaye, PhD, Heinrich Heine University, Germany
Tim Ahfeldt, PhD, Icahn School of Medicine at Mount Sinai, USA
Ramiro Alberio, PhD, University of Nottingham, UK
Juan Alvarez-Dominguez, PhD, Harvard University (Harvard Department of Stem Cell and Regenerative Biology), USA
Stelios T. Andreadis, PhD, University of Buffalo SUNY, USA
Anthony Atala, MD, Wake Forest School of Medicine, USA
Nick Barker, PhD, Institute of Molecular and Cell Biology (Epithelial Stem Cells Laboratory), A-STAR, Singapore
Milena Bellin, PhD, Leiden University Medical Center, NL
Semir Beyaz, PhD – Cold Spring Harbor Laboratory (Cancer Center), USA
Kapil Bharti, PhD, National Eye Institute, National Institutes of Health (Ocular and Stem Cell Translational Research Laboratiry), USA
Deepa Bhartiya, PhD, National Institute for Research in Reproductive Health, India
Joshua M. Brickman, PhD, University of Copenhagen DanStem, Denmark
Davide Cacchiarelli, PhD, Telethon Institute of Genetics and Medicine, Italy
Ian Chambers, PhD, MRC Centre for Regenerative Medicine, UK
Dong-Woo Cho, PhD, Pohang University of Science and Technology, South Korea
Irina M. Conboy, PhD, University of California Berkeley, USA
April M. Craft, PhD, Boston Children's Hospital (Dept of Orthopaedic Surgery, Stem Cells & Regenerative Biology), USA
Stephen L. Dalton, PhD, University of Georgia, USA
Deborah French, PhD, Children's Hospital of Philadelphia (Human Pluripotent Stem Cell Core), USA
Paul J. Gadue, PhD, Children's Hospital of Philadelphia (Pathology and Laboratory Medicine), USA
Anna-Katerina Hadjantonakis, PhD, Sloan Kettering Institute, USA
William Hendriks, PhD, Massachusetts General Hospital, Harvard Medical School (Department of Neurology), USA
Shijun Hu, PhD, Soochow University, China
John Hutchinson, PhD, Harvard Chan School of Public Health, USA
Dietmar W. Hutmacher, PhD, Queensland University of Technology, Australia
Rosario M. Isasi, JD, MPH, University of Miami, USA
Juan C. Izpisúa-Belmonte, PhD, Salk Institute, USA
Marianne F. James, PhD, Boston University (Center for Regenerative Medicine), USA
Mirosław Janowski, MD, PhD, Johns Hopkins University School of Medicine, USA
Nima Khadem Mohtaram, PhD, University of Waterloo, Canada
Justin D. Lathia, PhD, Lerner Research Institute Cleveland Clinic, USA
Ping Liang, MD, PhD, Zhejiang University, China
Charles P. Lin, PhD, Dana-Farber Institute, USA
Torsten Meissner, PhD, Harvard Medical School (Beth Israel Deaconess Medical Center), USA
Sally A. Moody, PhD, George Washington University, USA
Shruti Naik, PhD, New York University School of Medicine (Dept of Pathology), USA
Thao M. Nguyen, PhD, University of South Australia (Centre for Cancer Biology & Molecular Signaling Laboratory), Australia
Susan I. Nilsson, PhD, Australian Regenerative Medicine Institute, Australia
Jose Ordovas-Montanes, PhD – Boston Children's Hospital (Dept of Gastroenterology), USA
Kenji Osafune, MD, PhD, Tokyo University (Center for iPS Cell Research and Application), Japan
Vincent Pasque, PhD, University of Leuven (Dept of Development and Regeneration), Belgium
Ming Pei, MD, PhD, West Virginia University, USA
Shayn Peirce-Cottler, PhD, University of Virginia (Dept of Biomedical Engineering), USA
Michael Peitz, PhD, University of Bonn, Germany
Eric Pietras, PhD, University of Colorado Denver (Division of Hematology), USA
James K. Pru, PhD, Washington State University, USA
Pranela Rameshwar, PhD, Rutgers New Jersey Medical School, USA
Martin G. Rodriguez-Porcel, MD, Mayo Clinic (Dept of Cardiovascular Medicine), USA
George L. Sen, PhD, University of California San Diego, USA
Douglas Sipp, RIKEN, Japan
Guiomar Solanas, PhD, Institute for Research in Biomedicine (Oncology), Spain
Jose Teixeira, PhD, Michigan State University, USA
Adrian Teo, PhD, Institute of Molecular and Cell Biology (Stem Cells and Diabetes Laboratory), Singapore
Giuseppe Teste, MD, PhD, University of Milan (Department of Oncology and Hematology-Oncology), Milan, Italy
Gavin Tjin, PhD, St Vincent’s Institute of Medical Research (Stem Cell Regulation Unit), Australia
Wei Tong, PhD, Children's Hospital of Philadelphia (Abramson Research Center), USA
Rachel E. Truitt, PhD, University of Pennsylvania (Institute for Regenerative Medicine), USA
Kim Vanuytsel, PhD, Boston University (Center for Regenerative Medicine), USA
Li Wang, PhD, Fuwai Hospital National Center for Cardiovascular Diseases, China
Jessica L. Whited, PhD, Harvard University (Dept of Stem Cell and Regenerative Biology), USA
Jun Wu, PhD, University of Texas Southwestern Medical Center, USA
Chun-Li Zhang, PhD, University of Texas Southwestern Medical Center, USA

For the first volumes, the article processing charges (APCs) are significantly reduced (by 80%) to US$300 / EUR260 per published paper. 

Click here for further details about APCs and here for more information about the Open Access Mandates.
Go here to read more about the IOS Press Open Library® policy, as well as to check if there are any insitutional agreements that you might be eligible for.

Authors submitting a manuscript do so on the understanding that they have read and agreed to the terms of the IOS Press License to Publish and the IOS Press Privacy Policy.

The full instructions to authors & submission guidelines are available on the journal website here.



Niels Geijsen Appointed New Co-Editor-in-Chief of StemJournal

16 Jan 2020 - Amsterdam, NL – StemJournal is pleased to announce the expansion of its editorial leadership with the appointment of Niels Geijsen, PhD, as new Co-Editor-in-Chief. Niels joins Chad Cowan, PhD, who has served as Editor-in-Chief since the journal launched at the beginning of 2019. Together they will guide the development of this open access, peer-reviewed journal in its mission to provide cutting-edge, high quality content to the global stem cell research community....

Tissue Engineering Applications Combining Biomaterial Scaffolds with Stem Cells Will Facilitate Delivery of Targeted Therapies

24 Apr 2019 - Amsterdam, NL – StemJournal, a new open access, peer-reviewed journal published by IOS Press, announces publication of its inaugural article, “Combining Stem Cells and Biomaterial Scaffolds for Constructing Tissues and Cell Delivery” by Stephanie M. Willerth, PhD, and Shelly E. Sakiyama-Elbert, PhD. This timely overview of the available biomaterials for directing stem cell differentiation as a means of producing replacements for diseased or damaged tissues is a comprehensive update of the classic review published in StemBook in 2008....

IOS Press Relaunches StemBook

17 Dec 2018 - Amsterdam, NL – IOS Press, an international publisher providing content for scientific, technical and medical communities, is proud to announce the relaunch and revitalization of StemBook, an online open access forum and discussion platform for the stem cell research community. It features a collection of content covering a range of topics related to stem cell biology written by top researchers in the field. The site is being refreshed with new content that will be expanded and updated regularly. Enhanced functionality will also be introduced soon....